A randomized, double-blind, vehicle-controlled clinical study of hair regeneration using adipose-derived stem cell constituent extract in androgenetic alopecia

    August 2020 in “Stem Cells Translational Medicine
    Young Jin Tak, Sang Yup Lee, Jun-Sik Cho, Young Ho Kim
    Image of study
    TLDR ADSC-CE treatment safely increases hair density and thickness in androgenetic alopecia patients.
    The study investigated the efficacy and safety of adipose-derived stem cell constituent extract (ADSC-CE) in promoting hair growth in patients with androgenetic alopecia (AGA). The randomized, double-blind, vehicle-controlled clinical trial involved 38 participants who were assigned to receive either ADSC-CE or a placebo solution. The results showed that ADSC-CE treatment significantly increased hair density and thickness compared to the vehicle group, and was well-tolerated with no serious adverse events reported. The study suggests that ADSC-CE may be a safe and effective treatment option for AGA.
    View this study on academic.oup.com →

    Cited in this study

    Related